SARS-CoV-2 variants, vaccines, and host immunity

P Mistry, F Barmania, J Mellet, K Peta… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new beta coronavirus
that emerged at the end of 2019 in the Hubei province of China. SARS-CoV-2 causes …

Aging in COVID-19: Vulnerability, immunity and intervention

Y Chen, SL Klein, BT Garibaldi, H Li, C Wu… - Ageing research …, 2021 - Elsevier
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic was first
reported in Wuhan, China in December 2019, moved across the globe at an unprecedented …

FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation

C Junqueira, Â Crespo, S Ranjbar, LB De Lacerda… - Nature, 2022 - nature.com
SARS-CoV-2 can cause acute respiratory distress and death in some patients. Although
severe COVID-19 is linked to substantial inflammation, how SARS-CoV-2 triggers …

Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19

AK Azkur, M Akdis, D Azkur, M Sokolowska… - Allergy, 2020 - Wiley Online Library
As a zoonotic disease that has already spread globally to several million human beings and
possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID‐19) …

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2

S Yin, M Huang, D Li, N Tang - Journal of thrombosis and thrombolysis, 2021 - Springer
Abstract Severe coronavirus disease 2019 (COVID-19) is commonly complicated with
coagulopathy, the difference of coagulation features between severe pneumonia induced by …

Targeting the NLRP3 inflammasome in severe COVID-19

TL Freeman, TH Swartz - Frontiers in immunology, 2020 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of the genus
Betacoronavirus within the family Coronaviridae. It is an enveloped single-stranded positive …

COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?

S Colafrancesco, C Alessandri, F Conti, R Priori - Autoimmunity reviews, 2020 - Elsevier
The severe form of COVID-19 share several clinical and laboratory features with four entities
gathered under the term “hyperferritinemic syndromes” and including macrophage activation …

The immune system and COVID-19: Friend or foe?

F Yazdanpanah, MR Hamblin, N Rezaei - Life sciences, 2020 - Elsevier
Abstract Aim Coronavirus disease 2019 (COVID-19) is a novel highly contagious infection
caused by SARS-CoV-2, which has been became a global public health challenge. The …

[HTML][HTML] Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future …

B Ganesh, T Rajakumar, M Malathi… - … epidemiology and global …, 2021 - Elsevier
Abstract Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative
etiology of 'Corona Virus Disease-2019'(COVID-19); formerly referred as 'novel-Coronavirus …

Frontline Science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes

D Zhang, R Guo, L Lei, H Liu, Y Wang… - Journal of Leucocyte …, 2021 - academic.oup.com
Excessive monocyte/macrophage activation with the development of a cytokine storm and
subsequent acute lung injury, leading to acute respiratory distress syndrome (ARDS), is a …